About NovaCap
NovaCap is a Healthcare company based in Ecully (France) founded in 2003, and was acquired by Eurazeo in April 2016. Active pharmaceutical ingredients and intermediates are developed and manufactured. NovaCap has completed 3 acquisitions, including Chemoxy, ID Bio and PCI Synthesis. Its chief executive, as recorded, is Pierre Luzeau. Its focus areas include Biopharma Outsourcing, CDMO, Small Molecules & Peptides and API Production.
Company details
Founded in 2003 and based in Ecully, France, APIs and pharmaceutical intermediates are developed and manufactured. Key products encompass salicylic acid, aspirin, paracetamol, and compounds for gastrointestinal, cardiovascular, analgesic, and steroid uses. Custom research, innovation, development, and manufacturing services are provided within the pharmaceutical sector. Operations focus on supporting global supply needs for these materials.
- Headquarters Ecully, France
- Stage Acquired
- SectorsHealthcare
- Phone•••• ••••
- Website novacap.eu
- Social LinkedIn X
- Acquired by Eurazeo (Apr 2016)
Investors in NovaCap
NovaCap has secured backing from 2 investors, including venture fund investors. Prominent investors backing the company include Eurazeo and Ardian.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Private equity and debt investments are managed across multiple sectors. | 1969 | eurazeo.com | Paris, France | |
Private investment firm specializing in markets and partnerships. | ardian.com |
Investor details for NovaCap
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
People of NovaCap
1 people are tracked at NovaCap (1 in leadership).
| Name | Role | Group |
|---|---|---|
Pierre Luzeau | CEO & President | Leadership |
Complete people profiles for NovaCap
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Investments & Acquisitions by NovaCap
NovaCap has strategically engaged in corporate development activities, having acquired 3 companies. Notable acquisitions include Chemoxy, ID Bio and PCI Synthesis.
| Company Name | Description | Domain | Location | Founded | Acquired | Amount |
|---|---|---|---|---|---|---|
API manufacturing, custom synthesis, and scale-up services are provided. | pcisynthesis.com | Newburyport, United States | 1996 | Jun 2018 | •••• | |
Contract manufacturing of chemical intermediates is conducted. | chemoxy.com | Middlesbrough, United Kingdom | 1868 | Jul 2017 | •••• | |
CDMO focused on manufacturing of API products for biopharma sector | idbio.eu | Limoges, France | 1993 | May 2017 | •••• |
Complete acquisition details for NovaCap
Acquired stakes, deal sources and the complete acquisition history require an active premium plan.
- Acquired stakes
- Deal sources
- Complete history
- Exports
Verified entity values are shown only after access is granted.
Timeline of NovaCap
6 dated milestones of NovaCap across 15 years, from founding to its latest funding, stage changes and deals.
- Founded NovaCap is founded.
- Exit Acquired by Ardian.
- Exit Acquired by Eurazeo.
- Acquisition Acquires ID Bio.
- Acquisition Acquires Chemoxy.
- Acquisition Acquires PCI Synthesis.
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Novacap
Complete news archive for NovaCap
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about NovaCap
NovaCap was founded in 2003.
NovaCap is headquartered in Ecully, France. It is registered at Ecully, Auvergne-rhone-alpes, France.
Pierre Luzeau is the CEO of NovaCap, as recorded in our data.
Founded in 2003 and based in Ecully, France, APIs and pharmaceutical intermediates are developed and manufactured. Key products encompass salicylic acid, aspirin, paracetamol, and compounds for gastrointestinal, cardiovascular, analgesic, and steroid uses. Custom research, innovation, development, and manufacturing services are provided within the pharmaceutical sector. Operations focus on supporting global supply needs for these materials.
NovaCap has made 3 acquisitions, including Chemoxy, ID Bio, and PCI Synthesis.
Yes. NovaCap was acquired by Eurazeo in April 2016.